IL96501A - 14 alpha, 17 alpha-bridged estratrienes, processes for the preparation thereof, and pharmaceutical compositions containing them - Google Patents

14 alpha, 17 alpha-bridged estratrienes, processes for the preparation thereof, and pharmaceutical compositions containing them

Info

Publication number
IL96501A
IL96501A IL96501A IL9650190A IL96501A IL 96501 A IL96501 A IL 96501A IL 96501 A IL96501 A IL 96501A IL 9650190 A IL9650190 A IL 9650190A IL 96501 A IL96501 A IL 96501A
Authority
IL
Israel
Prior art keywords
alpha
processes
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL96501A
Other languages
English (en)
Other versions
IL96501A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3939894A external-priority patent/DE3939894A1/de
Priority claimed from DE3939893A external-priority patent/DE3939893A1/de
Priority claimed from DE4033871A external-priority patent/DE4033871A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL96501A0 publication Critical patent/IL96501A0/xx
Publication of IL96501A publication Critical patent/IL96501A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Fats And Perfumes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL96501A 1989-11-29 1990-11-29 14 alpha, 17 alpha-bridged estratrienes, processes for the preparation thereof, and pharmaceutical compositions containing them IL96501A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3939894A DE3939894A1 (de) 1989-11-29 1989-11-29 14(alpha),17(alpha)-ethano-16(alpha)-hydroxy-estratriene
DE3939893A DE3939893A1 (de) 1989-11-29 1989-11-29 14(alpha),17(alpha)-etha(e)no-16ss-hydroxy-estratriene
DE4033871A DE4033871A1 (de) 1990-10-22 1990-10-22 Verfahren zur herstellung von 14(alpha), 17(alpha)-etheno- und ethano-estriolen

Publications (2)

Publication Number Publication Date
IL96501A0 IL96501A0 (en) 1991-08-16
IL96501A true IL96501A (en) 1997-07-13

Family

ID=27200525

Family Applications (1)

Application Number Title Priority Date Filing Date
IL96501A IL96501A (en) 1989-11-29 1990-11-29 14 alpha, 17 alpha-bridged estratrienes, processes for the preparation thereof, and pharmaceutical compositions containing them

Country Status (21)

Country Link
US (1) US5529993A (xx)
EP (1) EP0430386B1 (xx)
JP (1) JP2996723B2 (xx)
KR (1) KR100203003B1 (xx)
CN (2) CN1057769C (xx)
AT (1) ATE122053T1 (xx)
AU (1) AU649239B2 (xx)
CA (1) CA2069880A1 (xx)
CZ (1) CZ286259B6 (xx)
DE (1) DE59009011D1 (xx)
DK (1) DK0430386T3 (xx)
ES (1) ES2074531T3 (xx)
FI (1) FI102902B (xx)
HU (1) HU220217B (xx)
IE (1) IE67321B1 (xx)
IL (1) IL96501A (xx)
NO (1) NO301232B1 (xx)
PH (1) PH31668A (xx)
PT (1) PT96035B (xx)
RU (1) RU2087479C1 (xx)
WO (1) WO1991008219A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4132182A1 (de) * 1991-09-24 1993-03-25 Schering Ag 11(beta)-substituierte 14, 17-ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln
DE4222316A1 (de) * 1992-07-03 1994-01-05 Schering Ag Verfahren zur Herstellung von Etheno- und Ethano-16â,17µ-Steroiddiolen und deren Derivaten
DE4447714C2 (de) * 1994-08-09 1998-02-05 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur Hormonsubstitutions-Therapie
DE4429397C2 (de) * 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
CN113999276B (zh) * 2020-07-28 2023-08-15 威智医药股份有限公司 一种去乙酰毛花苷中间体的提纯方法以及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE808679C (de) * 1948-10-19 1951-07-19 Hansen Neuerburg & Co Mit Leitflaechen versehene Propelleranordnung fuer Schiffe
DE3628189A1 (de) * 1986-08-20 1988-02-25 Schering Ag Oestrogen wirksame mittel und 14,17ss-ethano-14ss-estratriene
DE3808679A1 (de) * 1988-03-11 1989-09-21 Schering Ag Verfahren zur herstellung von 14,17(alpha)-etheno-1,3,5(10)-estratrienen

Also Published As

Publication number Publication date
HU9201805D0 (en) 1992-08-28
IL96501A0 (en) 1991-08-16
PT96035B (pt) 1998-01-30
FI920843A0 (fi) 1992-02-26
EP0430386B1 (de) 1995-05-03
CA2069880A1 (en) 1991-05-30
CN1117050A (zh) 1996-02-21
CN1052677A (zh) 1991-07-03
FI102902B1 (fi) 1999-03-15
IE67321B1 (en) 1996-03-20
DK0430386T3 (da) 1995-09-04
FI102902B (fi) 1999-03-15
CZ286259B6 (cs) 2000-02-16
HUT67420A (en) 1995-04-28
CN1057769C (zh) 2000-10-25
JP2996723B2 (ja) 2000-01-11
NO301232B1 (no) 1997-09-29
ES2074531T3 (es) 1995-09-16
JPH05503080A (ja) 1993-05-27
NO921910L (no) 1992-05-14
KR100203003B1 (ko) 1999-06-15
HU220217B (hu) 2001-11-28
CZ594390A3 (cs) 1999-11-17
RU2087479C1 (ru) 1997-08-20
DE59009011D1 (de) 1995-06-08
EP0430386A1 (de) 1991-06-05
PT96035A (pt) 1991-09-13
KR927003620A (ko) 1992-12-18
AU649239B2 (en) 1994-05-19
CN1031061C (zh) 1996-02-21
WO1991008219A1 (de) 1991-06-13
IE904316A1 (en) 1991-06-05
AU6884191A (en) 1991-06-26
US5529993A (en) 1996-06-25
ATE122053T1 (de) 1995-05-15
PH31668A (en) 1999-01-18
NO921910D0 (no) 1992-05-14

Similar Documents

Publication Publication Date Title
ES2115665T3 (es) Derivado de triterpeno.
ATE193886T1 (de) Glycerolipide verbindungen und ihre anwendung zum transport einer aktiven substanz in eine zielzelle
YU48840B (sh) Postupak za dobijanje substituisanih 1,3-oksatiolana sa antivirusnim osobinama
TR199701700T1 (xx) Bile�imler ve bu bile�imleri i�eren farmas�tik terkipler
ATE411335T1 (de) Östrogen-sulfamate als sulfataseinhibitoren
NZ212768A (en) 2-substituted-1,3-propylidene diphosphonate derivatives and pharmaceutical compositions
AU8577282A (en) Light-sensitive mixture and copying material prepared therefrom
IT1249732B (it) Oligonucleotidi antisenso.
IL96501A (en) 14 alpha, 17 alpha-bridged estratrienes, processes for the preparation thereof, and pharmaceutical compositions containing them
ATE49957T1 (de) Adamantanamin-derivate, verfahren zur herstellung und diese enthaltende heilmittel.
DK288686A (da) Farmaceutiske praeparater
MX170732B (es) Composicion de derivados de succinimida y su uso
GR3003575T3 (xx)
ATE169289T1 (de) Imido-percarbonsäuren
HK1032916A1 (en) N,n'-bis(sulfonyl)hydrazines useful as antineoplastic agents
RO87991A (ro) Procedeu pentru prepararea unor esteri tiazolidinici substituiti ai unor acizi minerali
AU1843097A (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
IL75545A0 (en) Substituted azabicycloheptanes,their manufacture and pharmaceutical compositions containing them
AR247737A1 (es) Un procedimiento para la fabricacion de compuestos.
ES2016931B3 (es) Procedimiento de preparación de nuevas amidas alifáticas y cicloalifáticas de piridilalquilaminas o de sus derivados N-óxidos.
GB2000967A (en) Malodor counteractants
KR950702566A (ko) 사슬형 아미딘기를 포함하는 디포스폰산 유도체, 그것의 제조방법 및 그것을 포함하는 의약 조성물(novel acyclic amidine-group-containing diphosphonic acid derivatives, process for producing them and medicaments containing these compounds)
PT86228A (de) Verfahren zur herstellung von 6alpha,9alpha-difluor-11beta,17alpha-dihydroxy-16alpha-methil-4-pregnen-3,20-dion und dessen derivate
PT87819A (pt) Procede de preparation de nouveaux derives de la 1-benzoyl 2-oxo 5-alcoxy pyrrolidine
MY105478A (en) A 14, 17 -bridged-16-hydroxy-trienes

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees